학술논문

DOSE‐ADJUSTED EPOCH‐RITUXIMAB OR INTENSIFIED B‐NHL‐BFM‐TYPE THERAPY FOR PEDIATRIC PRIMARY MEDIASTINAL B‐CELL LYMPHOMA.
Document Type
Article
Source
Hematological Oncology; Jun2021 Supplement S2, Vol. 39, p1-2, 2p
Subject
Language
ISSN
02780232